Topics

"A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis" Drugs and Medication Database

09:17 EST 27th February 2020 | BioPortfolio

Here are the most relevant "A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis" Drugs and Medications that we have found in our database.

More Information about "A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis" on BioPortfolio

We have published hundreds of A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis news stories on BioPortfolio along with dozens of A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Clinical Trials and PubMed Articles about A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Companies in our database. You can also find out about relevant A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis Drugs and Medications on this site too.

Showing "Study INCB050465 Combination With Ruxolitinib Subjects With Myelofibrosis" Drugs and Medications, all 12

Possibly Relevant

Jakafi [incyte corporation]

These highlights do not include all the information needed to use JAKAFI safely and effectively. See full prescribing information for JAKAFI. JAKAFI (ruxolitinib) tablets, for oral use Initial U.S. Approval: 2011

Fluoxetine [med-health pharma, llc]

These highlights do not include all the information needed to use fluoxetine safely and effectively. See full prescribing information for fluoxetine capsules. Fluoxetine Capsules, USP for Oral Use Initial U.S. Approval: 1987

Vinorelbine [sagent pharmaceuticals]

These highlights do not include all the information needed to use VINORELBINE INJECTION safely and effectively. See full prescribing information for VINORELBINE INJECTION. VINORELBINE injection, for intravenous useInitial U.S. Approval: 1994

Farydak [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use FARYDAK safely and effectively. See full prescribing information for FARYDAK. FARYDAK (panobinostat) capsules, for oral use Initial U.S. Approval: 2015

Repaglinide [rising health, llc]

These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively.  See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997

Repaglinide [aurobindo pharma limited]

These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively.  See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997

Docetaxel [amneal biosciences llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION.   DOCETAXEL injection, for intravenous use Initial U.S. Approval: 1996

Docetaxel [x-gen pharmaceuticals, inc.]

These highlights do not include all the information needed to use DOCETAXEL INJECTION USP (Injection Concentrate) safely and effectively. See full prescribing information for DOCETAXEL INJECTION USP (Injection Concentrate). DOCETAXEL Injection (Injection

Rebetol [merck sharp & dohme corp.]

These highlights do not include all the information needed to use REBETOL safely and effectively. See full prescribing information for REBETOL.REBETOL (ribavirin USP) capsules, for oral use REBETOL (ribavirin USP) oral solutionInitial U.S. Approval: 1998

Trilyte [alaven pharmaceutical llc]

TriLyte with flavor packs

Repaglinide [sun pharmaceutical industries, inc.]

These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS.REPAGLINIDE tablets, for oral useInitial U.S. Approval: 1997

Repaglinide [american health packaging]

These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 1997



Quick Search